Antibe Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (ATE)
Antibe Therapeutics Inc is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.
Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.
| Symbol | Name | Total Return | Period |
|---|---|---|---|
| HZM | Horizonte Minerals PLC | -94.736842 | YTD |
| TAIG | Taiga Motors Corp | -70.786517 | YTD |
| ATE | Antibe Therapeutics Inc | -68.27957 | YTD |
| BCT | BriaCell Therapeutics Corp | -61.538462 | YTD |
| VPH | Valeo Pharma Inc | -52.777778 | YTD |
| APS | Aptose Biosciences Inc | -50.447761 | YTD |
| SSRM | SSR Mining Inc | -47.398031 | YTD |
| NPK | Verde AgriTech Ltd | -46.496815 | YTD |
| LEV | The Lion Electric Co | -44.915254 | YTD |
| ECN | ECN Capital Corp | -44.666667 | YTD |
| EXRO | Exro Technologies Inc | -44.53125 | YTD |
| AVNT | Avant Brands Inc | -42.857143 | YTD |
| NEXT | NextSource Materials Inc | -42.5 | YTD |
| EGLX | Enthusiast Gaming Holdings Inc | -42.105263 | YTD |
| CNT | Century Global Commodities Corp | -40 | YTD |
| SVA | Sernova Corp | -38.571429 | YTD |
| GVC | Glacier Media Inc | -37.5 | YTD |
| FANS | Fansunite Entertainment Inc | -36.363636 | YTD |
| BRMI | Boat Rocker Media Inc | -34.615385 | YTD |
| GRN | Greenlane Renewables Inc | -34.615385 | YTD |
| XTRA | Xtract One Technologies Inc | -34.589041 | YTD |
| LPEN | Loop Energy Inc | -33.333333 | YTD |
| NCF | Northcliff Resources Ltd | -33.333333 | YTD |
| LSPD | Lightspeed Commerce Inc | -33.069734 | YTD |
| PMET | Patriot Battery Metals Inc | -32.729104 | YTD |
All data provided as of April 24, 2024.
More about Antibe Therapeutics Inc
Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. The company's pipeline includes assets that seek to overcome gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs. Antibe's lead drug, otenaproxesul, is in clinical development as a safer alternative to opioids for post-operative pain.
Antibe Therapeutics Inc is listed under ATE on the Toronto Stock Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
